ABVX US Equity

Abivax S.A.

Health Care · Pharmaceutical Preparations · CIK 1956827 · FY ends Dec 31

$120.56

+1.62 (+1.36%)

USD · as of 2026-08-19 · marketstack

Switch Ticker

Events

0 8-K filings · 1 13D · 2 13G

Date

Event

What happened / filer

Source

2026-08-14

13G/A

Schedule 13G amendment — ≥5% beneficial owner (passive) · by TCG Crossover GP I, LLC

2026-08-13

13G/A

Schedule 13G amendment — ≥5% beneficial owner (passive) · by Invus Global Management, LLC

2026-07-07

13D/A

Schedule 13D amendment — ≥5% beneficial owner (active intent) · by Sofinnova Crossover I

Source: SEC EDGAR (public domain) · history starts 2026-07-07

Every row is a filed document, checked against its EDGAR index.